PO232 A Systematic Review and Meta-Analysis of Prevalence Studies of White Coat and Masked Hypertension In Africa

Abstract Background and Aims Latest classification of hypertension based on ambulatory blood pressure measurement was normotension (NT), white coat hypertension (WCHT), masked hypertension (MHT), and sustained hypertension (SHT). Recent studies suggest that WCHT, MHT, and SHT increase risk of target organ damage, particularly albuminuria, although the results were still inconsistent. Albuminuria is not only the sign of early glomerular damage in CKD patients, but also the signs of hypertension progression and predictors for cardiovascular events mortality. This study aims to compare the albuminuria risk among NT and WCHT, MHT, also SHT in CKD patients. Method We searched the literature comprehensively in online databases of Pubmed, EMBASE, ScienceDirect, and Cochrane Library to include all relevant studies using predefined terms until December 2020. We included studies that analyzed the albuminuria risk and compared the log2 urinary albumin-to-creatinine ratio (ACR) among NT and WCHT, MHT, or SHT in CKD patients. We used the Newcastle-Ottawa Scale for Observational Study checklist for evaluating bias risks. Analysis of the studies was conducted to provide pooled Odds Ratio (OR) for albuminuria risk and standard mean difference (SMD) for log2 ACR comparison with 95% Confidence Interval (CI) with random-effect heterogeneity test. Results We included 7 observational studies met our inclusion criteria. WCHT increases albuminuria risk although not statistically significant (pooled OR = 1.72, 95%CI 0.97 to 3.07, p = 0.06, I2 = 75%), while MHT and SHT significantly increase albuminuria risk with pooled OR respectively 1.62 (95%CI 1.03 to 2.53, p = 0.04, I2 = 82%) and 3.17 (95%CI 1.66 to 6.05, p = 0.0005, I2 = 94%). Controlled hypertension significantly protects CKD patients against albuminuria risk based on log2 ACR comparison with WCHT (SMD = 0.52, 95%CI 0.38 to 0.67, p<0.00001, I2 = 0%), MHT (SMD = 0.34, 95%CI 0.19 to 0.49, p<0.0001, I2 = 39%), and SHT (SMD = 0.63, 95%CI 0.31 to 0.95, p=0.0001, I2 = 76%). Conclusion White coat hypertension, masked hypertension, and sustained hypertension increase albuminuria risks in CKD patients. However, further studies are needed to determine the causality.

Download Full-text

Research Protocol for Systematic Review and Meta-Analysis of Elder Abuse Prevalence Studies

Canadian Journal on Aging / La Revue canadienne du vieillissement ◽

10.1017/s0714980817000137 ◽

2017 ◽

Vol 36 (2) ◽

pp. 256-265 ◽

Cited By ~ 2

Author(s):

Yongjie Yon ◽

Christopher Mikton ◽

Zachary D. Gassoumis ◽

Kathleen H. Wilber

Keyword(s):

Systematic Review ◽

Systematic Reviews ◽

Elder Abuse ◽

Meta Analysis ◽

Personnes Âgées ◽

Nous Allons ◽

Research Protocol ◽

Prevalence Studies ◽

Revue Systématique ◽

Meta Regression

RÉSUMÉLa maltraitance des personnes âgées est un important problème de santé publique et de droits de l’homme. Néanmoins, notre connaissance de la veritable ampleur du phénomène demeure limitée. Pour y remédier, nous allons procéder à une revue systématique et une méta-analyse des études de prevalence de la maltraitance des personnes âgées dans le monde entier. Ce protocole décrit l’approche méthodologique qui sera adoptée pour la réalisation de la revue systématique et de la méta-analyse. En particulier, le protocole décrit le développement des stratégies de recherche et des critères pour identifier et sélectionner les études de prévalence ainsi que la façon dont les données des études sélectionnées seront extraites pour l’analyse. Le protocole décrit également l’approche analytique qui sera utilisée pour calculer les estimations de prevalence et l’utilisation de méta-régression pour évaluer la façon dont les caractéristiques des études influencent les estimations de la prévalence. Ce protocole est conforme au “Preferred Reporting Items for Systematic reviews and Meta-Analysis” – ou PRISMA – et a été enregistré auprès du registre de revues systématique PROSPERO International Prospective Register.

Download Full-text

COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis

Frontiers in Medicine ◽

10.3389/fmed.2021.681469 ◽

2021 ◽

Vol 8 ◽

Author(s):

Masoud Dadashi ◽

Saeedeh Khaleghnejad ◽

Parisa Abedi Elkhichi ◽

Mehdi Goudarzi ◽

Hossein Goudarzi ◽

...

Keyword(s):

Systematic Review ◽

Case Reports ◽

Influenza Infection ◽

Meta Analysis ◽

Clinical Manifestations ◽

Case Series ◽

Influenza Viruses ◽

Original Research ◽

Respiratory Pathogens ◽

Prevalence Studies

Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis.Methods: A systematic literature search was performed on September 28, 2019 for original research articles published in Medline, Web of Science, and Embase databases from December 2019 to September 2020 using relevant keywords. Patients of all ages with simultaneous COVID-19 and influenza were included. Statistical analysis was performed using STATA 14 software.Results: Eleven prevalence studies with total of 3,070 patients with COVID-19, and 79 patients with concurrent COVID-19 and influenza were selected for final evaluation. The prevalence of influenza infection was 0.8% in patients with confirmed COVID-19. The frequency of influenza virus co-infection among patients with COVID-19 was 4.5% in Asia and 0.4% in the America. Four prevalence studies reported the sex of patients, which were 30 men and 31 women. Prevalence of co-infection with influenza in men and women with COVID-19 was 5.3 and 9.1%, respectively. Eight case reports and 7 case series with a total of 123 patients with COVID-19 were selected, 29 of them (16 men, 13 women) with mean age of 48 years had concurrent infection with influenza viruses A/B. Fever, cough, and shortness of breath were the most common clinical manifestations. Two of 29 patients died (6.9%), and 17 out of 29 patients recovered (58.6%). Oseltamivir and hydroxychloroquine were the most widely used drugs used for 41.4, and 31% of patients, respectively.Conclusion: Although a low proportion of COVID-19 patients have influenza co-infection, however, the importance of such co-infection, especially in high-risk individuals and the elderly, cannot be ignored. We were unable to report the exact rate of simultaneous influenza in COVID-19 patients worldwide due to a lack of data from several countries. Obviously, more studies are needed to evaluate the exact effect of the COVID-19 and influenza co-infection in clinical outcomes.

Download Full-text

Differences In Chronic Pain Prevalence Between Men And Women At Mid-Life: A Systematic Review Protocol

10.21203/rs.3.rs-1192864/v1 ◽

2021 ◽

Author(s):

Catherine Borra ◽

Rebecca Hardy

Keyword(s):

Systematic Review ◽

Chronic Pain ◽

Life Course ◽

Assessment Tool ◽

Social Research ◽

Data Extraction ◽

Meta Analysis ◽

Men And Women ◽

Prevalence Studies ◽

The Life Course

Abstract Background: Epidemiological literature has revealed differences in chronic pain (CP) prevalence in men and women. Women have been found to be more likely to develop CP compared to men at different points of the life-course, such as childhood and old age. Less is known about differences in prevalence by sex during mid-life. While CP is most prevalent later in life, biological and physical changes in mid-life may predispose to an earlier differentiation in CP distribution – for example due to the menopause. The aim of this study is to describe the prevalence of CP at midlife in men and women, and to identify how these differences relate to results pertaining to other periods in the life-course. Methods: This systematic review follows PRISMA guidelines. An electronic search will identify appropriate studies in the following databases: MEDLINE, to be accessed through Web of Science; and EMBASE, AMED and PSYCHinfo to be accessed through OVID. Two reviewers will independently screen each title and abstract and subsequently each full text following the inclusion criteria outlined in this protocol. The reference lists of eligible papers will also be screened to identify any further eligible studies. Any inconsistencies between reviewer decisions will be resolved through discussion. Studies eligible for data extraction will report estimates of CP prevalence, of prevalence for each sex, and difference in prevalence between sexes. Two reviewers will conduct data extraction using a standardised data extraction form. Quality assessment will be conducted using a risk of bias assessment tool for prevalence studies. The findings will be reported in a narrative synthesis and will comment on expected heterogeneity, following the Social Research Council Methods Programme guidelines. A random effects meta-analysis will be conducted where the reviewers can justify combining results.Discussion: This review will summarise the prevalence of CP in men and women at mid-life, based on existing evidence. It is expected that the results will identify gaps in knowledge and areas for further research.Systematic review registration: PROSPERO: CRD42021295895

Download Full-text

Prevalence of smoking in adults with spinal cord stimulators: a systematic review and meta-analysis

Regional Anesthesia and Pain Medicine ◽

10.1136/rapm-2019-100996 ◽

2020 ◽

Vol 45 (3) ◽

pp. 214-218

Author(s):

W Michael Hooten ◽

Rajat N Moman ◽

Jodie Dvorkin ◽

E Morgan Pollard ◽

Robalee Wonderman ◽

...

Keyword(s):

Systematic Review ◽

Spinal Cord ◽

Smoking Status ◽

Meta Analysis ◽

Vascular Diseases ◽

Risk Of Bias ◽

Future Research ◽

Cross Sectional ◽

Prevalence Studies ◽

Pooled Prevalence

BackgroundSmoking adversely impacts pain-related outcomes of spinal cord stimulation (SCS). However, the proportion of SCS patients at risk of worse outcomes is limited by an incomplete knowledge of smoking prevalence in this population. Thus, the primary aim of this systematic review is to determine the prevalence of smoking in adults with chronic pain treated with SCS.MethodsA comprehensive search of databases from 1 January 1980 to 3 January 2019 was conducted. Eligible study designs included (1) randomized trials; (2) prospective and retrospective cohort studies; and (3) cross-sectional studies. The risk of bias was assessed using a tool specifically developed for prevalence studies. A total of 1619 records were screened, 19 studies met inclusion criteria, and the total number of participants was 10 838.ResultsThirteen studies had low or moderate risk of bias, and six had a high risk of bias. All 19 studies reported smoking status and the pooled prevalence was 38% (95% CI 30% to 47%). The pooled prevalence in 6 studies of peripheral vascular diseases was 56% (95% CI 42% to 69%), the pooled prevalence of smoking in 11 studies of lumbar spine diagnoses was 28% (95% CI 20% to 36%) and the pooled prevalence in 2 studies of refractory angina was 44% (95% CI 31% to 58%).ConclusionsThe estimated prevalence of smoking in SCS patients is 2.5 times greater than the general population. Future research should focus on development, testing and deployment of tailored smoking cessation treatments for SCS patients.

Download Full-text

MASKED HYPERTENSION AND CARDIOVASCULAR OUTCOMES: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)32459-8 ◽

2018 ◽

Vol 71 (11) ◽

pp. A1918

Author(s):

Arshad Ali Javed ◽

Mohan Palla ◽

Luis Afonso ◽

Alexandros Briasoulis

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Masked Hypertension

Download Full-text